Stocks · Korea
334970
KOSDAQ
Prestige Biologics
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+2.70%
1M-19.79%
3M-29.35%
6M-42.73%
1Y-61.48%
YTD-55.79%
52W high3,850원
52W low1,230원
From 52W high-63.48%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 15,565,702원 | -366억 | -497억 | -235,333.1% |
| 2023 | 17억 | -221억 | -180억 | -1,277.6% |
| 2024 | 22억 | -334억 | -294억 | -1,541.2% |
| 2025 | 125억 | -337억 | -275억 | -268.7% |
| Quarterly | ||||
| 2024 3Q | 6억 | -121억 | -158억 | -1,894.8% |
| 2024 4Q | -18억 | 9억 | 68억 | — |
| 2025 1Q | 12억 | -136억 | -129억 | -1,163.4% |
| 2025 2Q | 89억 | -97억 | -83억 | -109.5% |
| 2025 3Q | 35억 | -73억 | -75억 | -208.9% |
| 2025 4Q | -10억 | -31억 | 12억 | — |
Company
Address: 충청북도 청주시 흥덕구 오송읍 오송생명1로 197
Peers in the same sector
Recent filings
- 2026-09-28[기재정정]사업보고서 (2026.06)
- 2026-09-18사업보고서 (2026.06)
- 2026-06-22[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.